Gilead And Teva Drug Buyers Lose Bid For New Antitrust Trial – Law360

By Hailey Konnath (November 1, 2023, 11:54 PM EDT) — A California federal judge on Wednesday refused to grant HIV medication purchasers a new trial following a jury’s verdict clearing Gilead and Teva in a $3.6 billion antitrust case claiming they had an illicit agreement to delay generic versions of the drugs, finding that the jury’s decision was in line with the evidence presented and not a result of confusion as to the verdict form instructions….